2026 COA Annual Meeting Day 1: Incorporating the Patient Voice into Clinical Trial Design

Incorporating the Patient Voice into Clinical Trial Design: More Than Just Checking the Box Moderator: Nicki Bush, MHS – Global Head, Endpoint Strategy and COA Measurement, Patient-Centered Outcomes, OPEN Health Presenters: Pujita Vaidya, MPH – Director, Regulatory Science and Policy, North America, Sanofi Amanda Decoker, MA – Sr. Director, Head of Patient Engagement, Experience and Recruitment, Takeda Panelists: Cynthia Grossman, PhD – Division Director, Division of Patient-Centered Development, Center for Devices and Radiological Health, US Food and Drug Administration Samantha Parker, MBA – Patient Engagement Lead, Italfarmaco & Vice-Chair International Rare Disease Research Consortium Dominique Pichard, MD, MS – Chief Science Officer, International Rett Syndrome Foundation This year’s meeting will feature a session exploring how sponsors, regulators, and patient communities can work together to meaningfully integrate the patient voice throughout clinical trial design and execution. Topics include: Discuss strategic considerations around enhancing patient-focused medical product development Share practical considerations for executing patient engagement in clinical research Provide regulatory and patient perspectives related to incorporating the patient voice into clinical trial design SUBSCRIBE to C-Path's YouTube Channel Now ►►    / criticalpathinstitute   FOLLOW C-Path: ►LinkedIn:   / c-path   ►Facebook:   / cpathinstitute   ►Twitter: https://twitter.com/CPathInstitute?re About Critical Path Institute C-Path is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org. #CPath #drugdiscovery #researchgrants #globalhealth #drugdevelopment #datasharing #researchfunding #raredisease #academicresearch #regulatoryscience #globalhealth #consortia #collaboration